News Search Results
Apr 01, 2026, 06:30 ET Flagship Pioneering and AWS Announce Collaboration to Accelerate Drug Discovery and Life Sciences Innovation
Sana Biotechnology,
More news about: Flagship Pioneering
Apr 01, 2026, 03:00 ET ISHIHARA SANGYO KAISHA Refreshes Corporate Brand Identity and Unveils New Corporate Slogan: "Local Insight, Global Impact" -- Grounded in Community, Committed to Creating Value
development across both organic and inorganic chemistry, while pursuing growth in high-potential areas, including environmental solutions, energy, biotechnology, and IT.For more information, please visit: https://www.iskweb.co.jp/eng/
More news about: ISHIHARA SANGYO KAISHA, LTD.
Apr 01, 2026, 03:00 ET ISHIHARA SANGYO KAISHA Refreshes Corporate Brand Identity and Unveils New Corporate Slogan: "Local Insight, Global Impact" -- Grounded in Community, Committed to Creating Value
development across both organic and inorganic chemistry, while pursuing growth in high-potential areas, including environmental solutions, energy, biotechnology, and IT.For more information, please visit: https://www.iskweb.co.jp/eng/
More news about: ISHIHARA SANGYO KAISHA, LTD.
Mar 31, 2026, 19:00 ET NJ Bio, Inc. and Ajinomoto Bio‑Pharma Services Enter into Collaboration to Strengthen Support for Antibody-Drug Conjugate Development
additional chemistry facilities in Bristol, Pennsylvania and Mumbai, India. The company provides fully integrated chemistry and biology services to biotechnology and pharmaceutical companies, supporting programs from early discovery through GMP manufacturing. With deep expertise in bioconjugation, synthetic
More news about: Ajinomoto Bio-Pharma Services
Mar 31, 2026, 19:00 ET NJ Bio, Inc. and Ajinomoto Bio‑Pharma Services Enter into Collaboration to Strengthen Support for Antibody-Drug Conjugate Development
additional chemistry facilities in Bristol, Pennsylvania and Mumbai, India. The company provides fully integrated chemistry and biology services to biotechnology and pharmaceutical companies, supporting programs from early discovery through GMP manufacturing. With deep expertise in bioconjugation, synthetic
More news about: Ajinomoto Bio-Pharma Services
Mar 31, 2026, 16:45 ET Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2025 Financial Results
https://clinicaltrials.gov/study/NCT06556368).About Kodiak Sciences Inc.Kodiak Sciences (Nasdaq: KOD) is a precommercial retina-focused biotechnology company committed to researching, developing and commercializing transformative therapeutics. We are focused on bringing new science to the design
More news about: Kodiak Sciences Inc.
Mar 31, 2026, 15:24 ET CollectiveMinds LLC Places Robert Hollingsworth, PhD as Chief Scientific Officer of Protillion Biosciences
executive search firm specializing in life sciences and biotechnology, today announced the successful placement of Robert Hollingsworth, PhD, as Chief Scientific Officer of Protillion Biosciences, Inc. Protillion is an innovative, venture-backed biotechnology company headquartered in Carlsbad, California, backed
More news about: CollectiveMinds LLC
Mar 31, 2026, 14:17 ET INVESTOR ALERT: ImmunityBio, Inc. (IBRX) Investors with Substantial Losses Have Opportunity to Lead the ImmunityBio Class Action Lawsuit
[email protected] ALLEGATIONS: ImmunityBio is a biotechnology company that focuses on innovating, developing, and commercializing next-generation immunotherapies. According to the complaint, ImmunityBio's lead
More news about: Robbins Geller Rudman & Dowd LLP
Mar 31, 2026, 11:46 ET West Expands Dublin Facility to Support High-Volume Injectable Therapies, Including Diabetes and Obesity
and assembly, packaging, validation, analytical testing, and regulatory support. Through this integrated approach, West helps pharmaceutical and biotechnology partners accelerate time to market by delivering reliable, scalable solutions that support the global supply of life-enhancing and life-saving therapies.About
More news about: West Pharmaceutical Services, Inc.
Mar 31, 2026, 11:15 ET DeuteRx Celebrates Women's History Month with Over a Decade of Pioneering Leadership in Drug Discovery
life sciences executive and serial entrepreneur with more than 35 years of leadership in pharmaceutical and biotechnology companies. She has led the start-up or turnaround of numerous biotechnology companies and business units, orchestrated transactions valued at billions of dollars, and managed global
More news about: DeuteRx LLC
Mar 31, 2026, 09:20 ET NeuroSense Therapeutics Reports Year End 2025 Financial Results and Provides Business Update
NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense" or the "Company"), a late-stage clinical biotechnology company developing treatments for severe neurodegenerative diseases, today reported its financial results for the year ended December 31, 2025 and
More news about: NeuroSense
Mar 31, 2026, 09:11 ET Lupin Receives Tentative Approval from U.S. FDA for Sugammadex Injection
products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position
More news about: Lupin Pharmaceuticals, Inc.
Mar 31, 2026, 09:07 ET 2026 CANADA GAIRDNER AWARDS RECOGNIZE WORLD-LEADING SCIENTISTS FOR BREAKTHROUGH DISCOVERIES ADVANCING HUMAN HEALTH
of both bacteria and phages, Dr. Maxwell's research is opening new paths for fighting infections, managing antibiotic resistance, and advancing biotechnology, with broad benefits for human health. Dr. Aaron PhillipsAssociate Professor, Departments of Clinical Neurosciences, Cardiac
More news about: Gairdner Foundation
Mar 31, 2026, 08:39 ET HYDRINITY RetaXome™ Daily Retinal Hydrator Named NewBeauty Best Retinal Serum Following Landmark Clinical Publication
providers to describe RetaXome as the first true "hydrating retinoid." The publication reinforced the position of HYDRINITY at the intersection of biotechnology and dermatological skincare innovation."This recognition from NewBeauty comes at an especially meaningful time for our brand," said Keith
More news about: HYDRINITY Accelerated Skin Science
Mar 31, 2026, 08:15 ET LabConnect Launches SampleGISTICS® 2.0 to Digitize Clinical Trial Sample Capture
LabConnectLabConnect is a global provider of technology-enabled central laboratory services and functional service provider solutions for pharmaceutical, biotechnology and contract research organizations. The company connects laboratories, logistics, technology and scientific expertise through a decentralized laboratory
More news about: LabConnect
Mar 31, 2026, 08:15 ET LabConnect Launches SampleGISTICS® 2.0 to Digitize Clinical Trial Sample Capture
LabConnectLabConnect is a global provider of technology-enabled central laboratory services and functional service provider solutions for pharmaceutical, biotechnology and contract research organizations. The company connects laboratories, logistics, technology and scientific expertise through a decentralized
More news about: LabConnect
Mar 31, 2026, 08:05 ET Rigel Announces Publication of Final ARROW Clinical Trial Data on GAVRETO® (pralsetinib) in Patients with RET+ NSCLC in the Journal of Clinical Oncology
Calif., March 31, 2026 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced publication of the final data from the Phase 1/2 ARROW study evaluating pralsetinib
More news about: Rigel Pharmaceuticals, Inc.
Mar 31, 2026, 08:00 ET Kalohexis Appoints Tony Mitchell as Chief Financial Officer
NORTHBROOK, Ill., March 31, 2026 /PRNewswire/ -- Kalohexis, a clinical-stage biotechnology company harnessing the melanocortin system to shape the next era of metabolic disease care starting with obesity and cancer cachexia, today announced
More news about: Kalohexis
Mar 31, 2026, 08:00 ET OpenProtein.AI Expands Strategic Partnership with Boehringer Ingelheim to Advance AI-Driven Antibody Discovery
seamlessly into existing workflows," said Tristan Bepler, Ph.D., CEO, OpenProtein.AI. "This expanded partnership validates our vision of providing biotechnology and pharmaceutical companies with production-ready AI infrastructure that learns from their proprietary data and adapts to their specific development
More news about: OpenProtein.AI
Mar 31, 2026, 07:34 ET Virax Biolabs Achieves ISO Certifications, Laying Foundation for Regulated IVD Development and U.S. Clinical Validation
pathways, which may include an LDT route."About Virax Biolabs Group LimitedVirax Biolabs Group Limited is an innovative biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. Virax Biolabs Group Limited is developing T cell-based
More news about: Virax BioLabs Group Limited
Mar 31, 2026, 07:30 ET Soligenix Announces Recent Accomplishments and Year End 2025 Financial Results
procurement contracts with the U.S. Government or other countries, that it will be able to compete with larger and better financed competitors in the biotechnology industry, that changes in health care practice, third party reimbursement limitations and Federal and/or state health care reform initiatives will
More news about: SOLIGENIX, INC.
Mar 31, 2026, 06:45 ET Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders
life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company
Mar 31, 2026, 06:34 ET Diagens Biotechnology Raises US$101 Million in Hong Kong IPO; Shares More Than Double on First Day of Trading
HKEXHANGZHOU, China, March 31, 2026 /PRNewswire/ -- Hangzhou Diagens Biotechnology Co., Ltd. (HKEX: 02526) today began trading on the Main Board of The Stock Exchange of Hong Kong. Shares closed at HK$202.60, up 104.65% from the
More news about: Hangzhou Diagens Biotechnology Co., Ltd.
Mar 31, 2026, 06:30 ET Immunic Strengthens Its Board of Directors with the Appointment of Seasoned Biopharmaceutical Executive Jon Congleton
Immunic, Inc. (Nasdaq: IMUX), a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic diseases, today announced the appointment of Jon Congleton, a seasoned
More news about: Immunic, Inc.
Mar 31, 2026, 06:15 ET Epson Announces Authorized Distribution Alliance with Clayton Controls to Deliver Advanced Automation Solutions to the Southwest Region
of experience, Epson Robots delivers robots for precision assembly and material handling applications in the aerospace, appliance, automotive, biotechnology, consumer product, electronics, food processing, medical device, pharmaceutical, plastics, semiconductor, and telecommunication industries. For
More news about: Epson America, Inc.